Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Post by zenvestingon Mar 05, 2015 1:03pm
150 Views
Post# 23493948

Expansion of their leased space

Expansion of their leased spaceDid you notice in the MD&A that the company is will be leasing a second building beginning in June 2015? The second building is more expensive than their current space, so it looks like this could be a significant expansion. 

18.COMMITMENTS The Company signed an offer to lease for its premises at 405 Britannia Rd, Mississauga which commenced December 1, 2009 and expires November 30, 2014 when the rent becomes payable on a month-to-month basis. The annual rental payment for fiscal 2014 through termination is $91,627. On December 5, 2014 the Company negotiateda lease renewal for this location. The revised lease has a term of five years commencing January 1, 2015 and expires December 31, 2019. The annual rent will be: $94,354 (2015); $96,863 (2016); $99,481 (2017); $102,208 (2018); and $104,935 (2019). 


On November 17, 2014 the Company signed an offer to lease for its premises at 1660 Tech Avenue, Mississauga which will commence June 1, 2015. The lease agreement is for a period of 10 years and will expire May 31, 2025. The minimum lease payments for the first five years will be $159,250 annually and increase to $202,125 for years six to ten. 

Bullboard Posts